A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
Condition(s):Impaired Cognition; SchizophreniaLast Updated:December 13, 2011Unknown status
Hide Studies Not Open or Pending
Condition(s):Impaired Cognition; SchizophreniaLast Updated:December 13, 2011Unknown status
Condition(s):Mild to Severe Alzheimer’s DiseaseLast Updated:September 27, 2018Completed
Condition(s):Ischemic StrokeLast Updated:July 30, 2021Completed
Condition(s):Ischemic StrokeLast Updated:March 5, 2013Unknown status
Condition(s):Healthy AdultLast Updated:January 10, 2012Completed
Condition(s):Alzheimer’s DiseaseLast Updated:June 27, 2016Completed
Condition(s):Osteoarthritis; Femoral Head Necrosis; Rheumatoid ArthritisLast Updated:January 30, 2020Unknown status
Condition(s):End-Stage Renal DiseaseLast Updated:May 14, 2013Completed
Condition(s):HealthyLast Updated:February 17, 2021Completed
Condition(s):Parkinson Disease; Mild Cognitive ImpairmentLast Updated:September 28, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.